메뉴 건너뛰기




Volumn 14, Issue 10, 2015, Pages 2215-2227

R-ketorolac targets Cdc42 and Rac1 and alters ovarian cancer cell behaviors critical for invasion and metastasis

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; KETOROLAC; P21 ACTIVATED KINASE; PROTEIN CDC42; 4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT; GUANOSINE TRIPHOSPHATE; PROTEIN BINDING; PYRIMIDINE DERIVATIVE; RAC1 PROTEIN; RAC1 PROTEIN, HUMAN;

EID: 84946772117     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-15-0419     Document Type: Article
Times cited : (81)

References (53)
  • 2
    • 84875690627 scopus 로고    scopus 로고
    • Latest research and treatment of advanced-stage epithelial ovarian cancer
    • Coleman RL, Monk BJ, Sood AK, Herzog TJ. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol 2013;10: 211-24.
    • (2013) Nat Rev Clin Oncol , vol.10 , pp. 211-224
    • Coleman, R.L.1    Monk, B.J.2    Sood, A.K.3    Herzog, T.J.4
  • 3
    • 84886802501 scopus 로고    scopus 로고
    • The role of the fallopian tube in the origin of ovarian cancer
    • Erickson BK, Conner MG, LandenCNJr. The role of the fallopian tube in the origin of ovarian cancer. Am J Obstet Gynecol 2013;209:409-14.
    • (2013) Am J Obstet Gynecol , vol.209 , pp. 409-414
    • Erickson, B.K.1    Conner, M.G.2    Landen, C.N.3
  • 4
    • 47549085187 scopus 로고    scopus 로고
    • Phenotypic plasticity of neoplastic ovarian epithelium: Unique cadherin profiles in tumor progression
    • Hudson LG, Zeineldin R, Stack MS. Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clin Exp Metastasis 2008;25:643-55.
    • (2008) Clin Exp Metastasis , vol.25 , pp. 643-655
    • Hudson, L.G.1    Zeineldin, R.2    Stack, M.S.3
  • 5
    • 84925966184 scopus 로고    scopus 로고
    • Exploiting the critical perioperative period to improve long-term cancer outcomes
    • Horowitz M, Neeman E, Sharon E, Ben-Eliyahu S. Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol 2015;12:213-26.
    • (2015) Nat Rev Clin Oncol , vol.12 , pp. 213-226
    • Horowitz, M.1    Neeman, E.2    Sharon, E.3    Ben-Eliyahu, S.4
  • 6
    • 84868093750 scopus 로고    scopus 로고
    • NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: Particular relevance to triple negative subgroup
    • Retsky M, Rogers R, Demicheli R, Hrushesky WJ, Gukas I, Vaidya JS, et al. NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup. Breast Cancer Res Treat 2012;134:881-8.
    • (2012) Breast Cancer Res Treat , vol.134 , pp. 881-888
    • Retsky, M.1    Rogers, R.2    Demicheli, R.3    Hrushesky, W.J.4    Gukas, I.5    Vaidya, J.S.6
  • 7
    • 84908424942 scopus 로고    scopus 로고
    • Rho GTPases: Masters of cell migration
    • Sadok A, Marshall CJ. Rho GTPases: masters of cell migration. Small GTPases 2014;5:e29710.
    • (2014) Small GTPases , vol.5 , pp. e29710
    • Sadok, A.1    Marshall, C.J.2
  • 8
    • 84862550404 scopus 로고    scopus 로고
    • Rho GTPase signaling in the development of colorectal cancer
    • Leve F, Morgado-Diaz JA. Rho GTPase signaling in the development of colorectal cancer. J Cell Biochem 2012;113:2549-59.
    • (2012) J Cell Biochem , vol.113 , pp. 2549-2559
    • Leve, F.1    Morgado-Diaz, J.A.2
  • 9
    • 84878650360 scopus 로고    scopus 로고
    • Role of activated rac1/cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer
    • Ma J, Xue Y, Liu W, Yue C, Bi F, Xu J, et al. Role of activated rac1/cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer. PLoS ONE 2013;8:e66275.
    • (2013) PLoS ONE , vol.8 , pp. e66275
    • Ma, J.1    Xue, Y.2    Liu, W.3    Yue, C.4    Bi, F.5    Xu, J.6
  • 11
    • 84938058544 scopus 로고    scopus 로고
    • Rac1 expression in epithelial ovarian cancer: Effect on cell EMT and clinical outcome
    • Leng R, Liao G, Wang H, Kuang J, Tang L. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome. Med Oncol 2015;32:329.
    • (2015) Med Oncol , vol.32 , pp. 329
    • Leng, R.1    Liao, G.2    Wang, H.3    Kuang, J.4    Tang, L.5
  • 12
    • 84946818704 scopus 로고    scopus 로고
    • A novel pharmacologic activity of ketorolac for therapeutic benefit in ovarian cancer patients
    • Jun 12. [Epub ahead of print]
    • Guo Y, Kenney SR, Cook L, Adams S, Rutledge T, Romero E, et al. A novel pharmacologic activity of ketorolac for therapeutic benefit in ovarian cancer patients. Clin Cancer Res. 2015 Jun 12. [Epub ahead of print].
    • (2015) Clin Cancer Res.
    • Guo, Y.1    Kenney, S.R.2    Cook, L.3    Adams, S.4    Rutledge, T.5    Romero, E.6
  • 13
    • 84863968373 scopus 로고    scopus 로고
    • Molecular pathways: Targeting p21-activated kinase 1 signaling in cancer-opportunities, challenges, and limitations
    • Eswaran J, Li DQ, Shah A, Kumar R. Molecular pathways: targeting p21-activated kinase 1 signaling in cancer-opportunities, challenges, and limitations. Clin Cancer Res 2012;18:3743-9.
    • (2012) Clin Cancer Res , vol.18 , pp. 3743-3749
    • Eswaran, J.1    Li, D.Q.2    Shah, A.3    Kumar, R.4
  • 14
    • 84907445756 scopus 로고    scopus 로고
    • Molecular pathways: Targeting RAC-p21-activated serine-threonine kinase signaling in RAS-driven cancers
    • Baker NM, Yee Chow H, Chernoff J, Der CJ. Molecular pathways: targeting RAC-p21-activated serine-threonine kinase signaling in RAS-driven cancers. Clin Cancer Res 2014;20:4740-6.
    • (2014) Clin Cancer Res , vol.20 , pp. 4740-4746
    • Baker, N.M.1    Yee Chow, H.2    Chernoff, J.3    Der, C.J.4
  • 16
    • 84894498866 scopus 로고    scopus 로고
    • Rac1-mediated effects of HMG-CoA reductase inhibitors (Statins) in cardiovascular disease
    • Adam O, Laufs U. Rac1-mediated effects of HMG-CoA reductase inhibitors (Statins) in cardiovascular disease. Antioxid Redox Signal 2014;20: 1238-50.
    • (2014) Antioxid Redox Signal , vol.20 , pp. 1238-1250
    • Adam, O.1    Laufs, U.2
  • 17
    • 84891107346 scopus 로고    scopus 로고
    • Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer
    • Sendur MA, Aksoy S, Yazici O, Ozdemir NY, Zengin N, Altundag K. Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer. Med Oncol 2014;31:835.
    • (2014) Med Oncol , vol.31 , pp. 835
    • Sendur, M.A.1    Aksoy, S.2    Yazici, O.3    Ozdemir, N.Y.4    Zengin, N.5    Altundag, K.6
  • 18
    • 84907478534 scopus 로고    scopus 로고
    • Statin use after colorectal cancer diagnosis and survival: A population-based cohort study
    • Cardwell CR, Hicks BM, Hughes C, Murray LJ. Statin use after colorectal cancer diagnosis and survival: a population-based cohort study. J Clin Oncol 2014;32:3177-83.
    • (2014) J Clin Oncol , vol.32 , pp. 3177-3183
    • Cardwell, C.R.1    Hicks, B.M.2    Hughes, C.3    Murray, L.J.4
  • 19
    • 84927087932 scopus 로고    scopus 로고
    • Statin use and risk of pancreatic cancer: Results from a large, clinic-based case-control study
    • Walker EJ, Ko AH, Holly EA, Bracci PM. Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study. Cancer 2015; 121:1287-94.
    • (2015) Cancer , vol.121 , pp. 1287-1294
    • Walker, E.J.1    Ko, A.H.2    Holly, E.A.3    Bracci, P.M.4
  • 20
    • 84905906596 scopus 로고    scopus 로고
    • Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: A retrospective cohort analysis
    • Habis M, Wroblewski K, Bradaric M, Ismail N, Yamada SD, Litchfield L, et al. Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis. PLoS ONE 2014;9:e104521.
    • (2014) PLoS ONE , vol.9 , pp. e104521
    • Habis, M.1    Wroblewski, K.2    Bradaric, M.3    Ismail, N.4    Yamada, S.D.5    Litchfield, L.6
  • 21
    • 2442664118 scopus 로고    scopus 로고
    • Rational design and characterization of a Rac GTPase-specific small molecule inhibitor
    • Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci U S A 2004;101:7618-23.
    • (2004) Proc Natl Acad Sci U S A , vol.101 , pp. 7618-7623
    • Gao, Y.1    Dickerson, J.B.2    Guo, F.3    Zheng, J.4    Zheng, Y.5
  • 24
    • 0034017744 scopus 로고    scopus 로고
    • Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases
    • Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, et al. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 2000;57:976-83.
    • (2000) Mol Pharmacol , vol.57 , pp. 976-983
    • Ishizaki, T.1    Uehata, M.2    Tamechika, I.3    Keel, J.4    Nonomura, K.5    Maekawa, M.6
  • 26
    • 84946818706 scopus 로고    scopus 로고
    • Mississauga, Ontario [cited 2015 Feb 19]
    • ® [Internet]. Mississauga, Ontario [cited 2015 Feb 19]. Available from: http://www.rochecanada.com/content/dam/internet/corporate/rochecanada/en-CA/documents/Research/ClinicalTrialsForms/Products/ConsumerInformation/MonographsandPublicAdvisories/Toradol/Toradol-PM-CIE.pdf.
    • ® [Internet]
  • 28
    • 0033028718 scopus 로고    scopus 로고
    • Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat
    • Jett MF, Ramesha CS, Brown CD, Chiu S, Emmett C, Voronin T, et al. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. J Pharmacol Exp Ther 1999;288: 1288-97.
    • (1999) J Pharmacol Exp Ther , vol.288 , pp. 1288-1297
    • Jett, M.F.1    Ramesha, C.S.2    Brown, C.D.3    Chiu, S.4    Emmett, C.5    Voronin, T.6
  • 29
    • 84892798809 scopus 로고    scopus 로고
    • Neutrophil: Lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery
    • Forget P, Machiels JP, Coulie PG, Berliere M, Poncelet AJ, Tombal B, et al. Neutrophil: lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery. Ann Surg Oncol 2013;20 Suppl 3: S650-60.
    • (2013) Ann Surg Oncol , vol.20 , pp. S650-S660
    • Forget, P.1    Machiels, J.P.2    Coulie, P.G.3    Berliere, M.4    Poncelet, A.J.5    Tombal, B.6
  • 30
    • 84946749324 scopus 로고    scopus 로고
    • Peri-operative ketorolac is associated with improved epithelial ovarian cancer survival
    • Mahller Y, Walsh C, Cass I, Rimel B, Karlan B, Li A. Peri-operative ketorolac is associated with improved epithelial ovarian cancer survival. Gynecol Oncol 2012;127:S25.
    • (2012) Gynecol Oncol , vol.127 , pp. S25
    • Mahller, Y.1    Walsh, C.2    Cass, I.3    Rimel, B.4    Karlan, B.5    Li, A.6
  • 31
    • 84868138680 scopus 로고    scopus 로고
    • A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: The DoCaCel study
    • Reyners AK, de Munck L, Erdkamp FL, Smit WM, Hoekman K, Lalisang RI, et al. A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study. Ann Oncol 2012; 23:2896-902.
    • (2012) Ann Oncol , vol.23 , pp. 2896-2902
    • Reyners, A.K.1    De Munck, L.2    Erdkamp, F.L.3    Smit, W.M.4    Hoekman, K.5    Lalisang, R.I.6
  • 32
    • 84883765692 scopus 로고    scopus 로고
    • Perioperative ketorolac in high risk breast cancer patients. Rationale, feasibility and methodology of a prospective randomized placebo-controlled trial
    • Forget P, Berliere M, van Maanen A, Duhoux FP, Machiels JP, Coulie PG, et al. Perioperative ketorolac in high risk breast cancer patients. Rationale, feasibility and methodology of a prospective randomized placebo-controlled trial. Med Hypotheses 2013;81:707-12.
    • (2013) Med Hypotheses , vol.81 , pp. 707-712
    • Forget, P.1    Berliere, M.2    Van Maanen, A.3    Duhoux, F.P.4    Machiels, J.P.5    Coulie, P.G.6
  • 33
    • 50049120233 scopus 로고    scopus 로고
    • Flow cytometry for real-time measurement of guanine nucleotide binding and exchange by Ras-like GTPases
    • Schwartz SL, Tessema M, Buranda T, Pylypenko O, Rak A, Simons PC, et al. Flow cytometry for real-time measurement of guanine nucleotide binding and exchange by Ras-like GTPases. Anal Biochem 2008;381:258-66.
    • (2008) Anal Biochem , vol.381 , pp. 258-266
    • Schwartz, S.L.1    Tessema, M.2    Buranda, T.3    Pylypenko, O.4    Rak, A.5    Simons, P.C.6
  • 34
    • 84885449964 scopus 로고    scopus 로고
    • Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells
    • Jacob A, Jing J, Lee J, Schedin P, Gilbert SM, Peden AA, et al. Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells. J Cell Sci 2013;126:4647-58.
    • (2013) J Cell Sci , vol.126 , pp. 4647-4658
    • Jacob, A.1    Jing, J.2    Lee, J.3    Schedin, P.4    Gilbert, S.M.5    Peden, A.A.6
  • 36
    • 34447345507 scopus 로고    scopus 로고
    • Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients
    • Shepherd TG, Theriault BL, Campbell EJ, Nachtigal MW. Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc 2006;1:2643-9.
    • (2006) Nat Protoc , vol.1 , pp. 2643-2649
    • Shepherd, T.G.1    Theriault, B.L.2    Campbell, E.J.3    Nachtigal, M.W.4
  • 37
    • 84862549205 scopus 로고    scopus 로고
    • A competitive nucleotide binding inhibitor: In vitro characterization of Rab7 GTPase inhibition
    • Agola JO, Hong L, Surviladze Z, Ursu O, Waller A, Strouse JJ, et al. A competitive nucleotide binding inhibitor: in vitro characterization of Rab7 GTPase inhibition. ACS Chem Biol 2012;7:1095-108.
    • (2012) ACS Chem Biol , vol.7 , pp. 1095-1108
    • Agola, J.O.1    Hong, L.2    Surviladze, Z.3    Ursu, O.4    Waller, A.5    Strouse, J.J.6
  • 39
    • 0034971799 scopus 로고    scopus 로고
    • Cell adhesion assays
    • Humphries MJ. Cell adhesion assays. Mol Biotechnol 2001;18:57-61.
    • (2001) Mol Biotechnol , vol.18 , pp. 57-61
    • Humphries, M.J.1
  • 40
    • 69449087383 scopus 로고    scopus 로고
    • Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: Implications for epithelial cell adhesion molecule-specific immunotherapy
    • Bellone S, Siegel ER, Cocco E, Cargnelutti M, Silasi DA, Azodi M, et al. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy. Int J Gynecol Cancer 2009;19:860-6.
    • (2009) Int J Gynecol Cancer , vol.19 , pp. 860-866
    • Bellone, S.1    Siegel, E.R.2    Cocco, E.3    Cargnelutti, M.4    Silasi, D.A.5    Azodi, M.6
  • 41
    • 69249213928 scopus 로고    scopus 로고
    • Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer
    • Taylor DD, Gercel-Taylor C, Parker LP. Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol Oncol 2009;115:112-20.
    • (2009) Gynecol Oncol , vol.115 , pp. 112-120
    • Taylor, D.D.1    Gercel-Taylor, C.2    Parker, L.P.3
  • 42
    • 84879101332 scopus 로고    scopus 로고
    • PAK family kinases: Physiological roles and regulation
    • Zhao ZS, Manser E. PAK family kinases: physiological roles and regulation. Cell Logist 2012;2:59-68.
    • (2012) Cell Logist , vol.2 , pp. 59-68
    • Zhao, Z.S.1    Manser, E.2
  • 44
    • 0032478605 scopus 로고    scopus 로고
    • A GTPase-independent mechanism of p21-activated kinase activation. Regulation by sphingosine and other biologically active lipids
    • Bokoch GM, Reilly AM, Daniels RH, King CC, Olivera A, Spiegel S, et al. A GTPase-independent mechanism of p21-activated kinase activation. Regulation by sphingosine and other biologically active lipids. J Biol Chem 1998;273:8137-44.
    • (1998) J Biol Chem , vol.273 , pp. 8137-8144
    • Bokoch, G.M.1    Reilly, A.M.2    Daniels, R.H.3    King, C.C.4    Olivera, A.5    Spiegel, S.6
  • 45
    • 84879640742 scopus 로고    scopus 로고
    • Cyclooxygenase-2 deficiency in macrophages leads to defective p110gamma PI3K signaling and impairs cell adhesion and migration
    • Diaz-Munoz MD, Osma-Garcia IC, Iniguez MA, Fresno M. Cyclooxygenase-2 deficiency in macrophages leads to defective p110gamma PI3K signaling and impairs cell adhesion and migration. J Immunol 2013;191: 395-406.
    • (2013) J Immunol , vol.191 , pp. 395-406
    • Diaz-Munoz, M.D.1    Osma-Garcia, I.C.2    Iniguez, M.A.3    Fresno, M.4
  • 46
    • 80053444351 scopus 로고    scopus 로고
    • Filopodia and adhesion in cancer cell motility
    • Arjonen A, Kaukonen R, Ivaska J. Filopodia and adhesion in cancer cell motility. Cell Adh Migr 2011;5:421-30.
    • (2011) Cell Adh Migr , vol.5 , pp. 421-430
    • Arjonen, A.1    Kaukonen, R.2    Ivaska, J.3
  • 47
    • 44349179335 scopus 로고    scopus 로고
    • Filopodia: Molecular architecture and cellular functions
    • Mattila PK, Lappalainen P. Filopodia: molecular architecture and cellular functions. Nat Rev Mol Cell Biol 2008;9:446-54.
    • (2008) Nat Rev Mol Cell Biol , vol.9 , pp. 446-454
    • Mattila, P.K.1    Lappalainen, P.2
  • 48
    • 84856287423 scopus 로고    scopus 로고
    • Cell migration and invasion in human disease: The Tks adaptor proteins
    • Courtneidge SA. Cell migration and invasion in human disease: the Tks adaptor proteins. Biochem Soc Trans 2012;40:129-32.
    • (2012) Biochem Soc Trans , vol.40 , pp. 129-132
    • Courtneidge, S.A.1
  • 49
    • 70249105718 scopus 로고    scopus 로고
    • Activation of RhoGTPases by DOCK exchange factors is mediated by a nucleotide sensor
    • Yang J, Zhang Z, Roe SM, Marshall CJ, Barford D. Activation of RhoGTPases by DOCK exchange factors is mediated by a nucleotide sensor. Science 2009;325:1398-402.
    • (2009) Science , vol.325 , pp. 1398-1402
    • Yang, J.1    Zhang, Z.2    Roe, S.M.3    Marshall, C.J.4    Barford, D.5
  • 50
    • 78049405035 scopus 로고    scopus 로고
    • Molecular basis for cyclooxygenase inhibition by the nonsteroidal anti-inflammatory drug naproxen
    • Duggan KC, Walters MJ, Musee J, Harp JM, Kiefer JR, Oates JA, et al. Molecular basis for cyclooxygenase inhibition by the nonsteroidal anti-inflammatory drug naproxen. J Biol Chem 2010;285: 34950-9.
    • (2010) J Biol Chem , vol.285 , pp. 34950-34959
    • Duggan, K.C.1    Walters, M.J.2    Musee, J.3    Harp, J.M.4    Kiefer, J.R.5    Oates, J.A.6
  • 51
    • 77953218308 scopus 로고    scopus 로고
    • Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis
    • Forget P, Vandenhende J, Berliere M, Machiels JP, Nussbaum B, Legrand C, et al. Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis. Anesth Analg 2010;110:1630-5.
    • (2010) Anesth Analg , vol.110 , pp. 1630-1635
    • Forget, P.1    Vandenhende, J.2    Berliere, M.3    Machiels, J.P.4    Nussbaum, B.5    Legrand, C.6
  • 52
    • 0034791297 scopus 로고    scopus 로고
    • NSAIDs inhibit alpha v beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis
    • Dormond O, Foletti A, Paroz C, Ruegg C. NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nat Med 2001;7:1041-7.
    • (2001) Nat Med , vol.7 , pp. 1041-1047
    • Dormond, O.1    Foletti, A.2    Paroz, C.3    Ruegg, C.4
  • 53
    • 84885611918 scopus 로고    scopus 로고
    • RAC1: An emerging therapeutic option for targeting cancer angiogenesis and metastasis
    • Bid HK, Roberts RD, Manchanda PK, Houghton PJ. RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis. Mol Cancer Ther 2013;12:1925-34.
    • (2013) Mol Cancer Ther , vol.12 , pp. 1925-1934
    • Bid, H.K.1    Roberts, R.D.2    Manchanda, P.K.3    Houghton, P.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.